ArticleBreast cancer research : BCR2025

Trastuzumab deruxtecan in patients with active brain metastases from HER2-positive/low metastatic breast cancer: a retrospective multicenter real-world study.

Fangfang Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.